Vanderbilt Institute for Clinical and Translational Research (VICTR) Archive — Page 1 of 7

October 6, 2026

Behind eMERGE’s genetic risk reports, a data platform built at Vanderbilt Health

A recent study shows what’s involved in bringing polygenic risk to bear in chronic disease clinical decision-making.

By Paul Govern
September 22, 2026

Vanderbilt Health to lead nationwide initiative to improve outcomes for critically ill patients

Funded via ARPA-H, CIRCLE will combine advances in diagnostics and AI to speed development of next-generation interventions that identify and respond to harmful immunoinflammatory states before life-threatening complications occur.

By Bill Snyder
September 7, 2026

REDCap adds generative AI tools, with human oversight built in

Institutions were advised to connect REDCap to their own institutionally managed, secure generative AI service.

By Paul Govern
August 4, 2026

Research that reaches patients: A conversation with Wesley Self and Jill Pulley

Research and art both approach the world with a fresh perspective. This art gallery features work by undergraduate student artists who participated in the Vanderbilt Institute for Infection, Immunology and Inflammation Artist-in-Residence (VI4-AiR) program. Supported by the Burroughs Wellcome Fund, the VI4-AiR program brings together scientists and artists to create and promote art as a visual science communication tool.

June 5, 2026

New research: Heart drug may also limit the spread of cancer

For the past 20 years, Vanderbilt Health researchers have been studying ifetroban for its potential to treat conditions ranging from fibrotic lung disease to heart failure in patients with Duchenne muscular dystrophy.

By Bill Snyder
May 26, 2026

Learning Health System holds seventh annual symposium 

By Susan Urmy